Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insomnia, A Comorbidity to Take Into Account in the Global Management of Patients With Irritable Bowel Syndrome?

Neurogastroenterology and motility·2026
Same author

Symptom Patterns Outside the Rome IV Consensus in Eastern and Western Patients With a Disorder of Gut-Brain Interaction.

The American journal of gastroenterology·2026
Same author

Fructose malabsorption induces dysbiosis and increases anxiety in male human and animal models.

Brain, behavior, and immunity·2025
Same author

First genome-wide association study reveals immune-mediated aetiopathology in idiopathic achalasia.

Gut·2025
Same author

Letter to the Editor.

The American journal of gastroenterology·2025
Same author

Consensus on the Management of Anesthetic Agents During Digestive Motility Measurements and Proposal of a Standardized Protocol for Anesthesia (French Neuro Gastroenterology Group GFNG and Committee of Anesthetic French Experts).

Neurogastroenterology and motility·2025

Related Experiment Videos

[Gastroparesis: pathophysiology and management].

Philippe Ducrotté1, Guillaume Gourcerol

  • 1Faculté de médecine et de pharmacie, ADEN EA 4311 hôpital Charles-Nicolle, département d'hépatogastroentérologie et de nutrition, Rouen cedex, France. philippe.ducrotte@chu-rouen.fr

Presse Medicale (Paris, France : 1983)
|December 14, 2011
PubMed
Summary

Gastroparesis prevalence is rising, often linked to diabetes or surgery. While erythromycin offers symptomatic relief, especially intravenously, its effectiveness diminishes over time and with high blood sugar.

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Endocrinology

Background:

  • Gastroparesis prevalence is increasing globally.
  • Key causes include diabetes mellitus and post-surgical complications, with idiopathic and post-infectious cases also noted.
  • Gastroparesis significantly complicates glycemic control in diabetic patients.

Purpose of the Study:

  • To review the diagnosis and management of gastroparesis.
  • To evaluate the efficacy of various therapeutic interventions.

Main Methods:

  • Literature review of gastroparesis causes, diagnosis, and treatment.
  • Analysis of symptomatic efficacy of prokinetic agents, particularly erythromycin.
  • Assessment of alternative therapies for refractory cases.

Main Results:

  • Gastric emptying studies are crucial for diagnosis due to unreliable symptoms.
  • Intravenous erythromycin shows higher symptomatic efficacy than other prokinetics, but this is reduced by hyperglycemia and tachyphylaxis.
  • Enteral feeding (duodenal/jejunal) and gastric electrical stimulation are effective for refractory gastroparesis, unlike endoscopic interventions.

Conclusions:

  • Early diagnosis and management are essential for improving patient outcomes.
  • Erythromycin is a valuable tool but requires careful administration considering patient factors and treatment duration.
  • Advanced therapies are necessary for managing refractory gastroparesis.